CL3-06790-010-laysummary-2021.01.07

Home » The efficacy and safety of trimetazidine in patients with angina pectoris having been treated by percutaneous coronary intervention ATPCI study. An international, multicentre, randomised, double-blind, placebo-controlled study in patients treated for 2 to 4 years. » CL3-06790-010-laysummary-2021.01.07

© 2024 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.

Accessibility